As hospital advocates prepared to begin their annual summer visits to Capitol Hill this week, five congressional Democrats signed on [...] …
Year: 2024
An anti-government waste group with ties to the drug industry is urging lawmakers to “stop the feeding frenzy” in the [...] …
Editor’s Note: In Tuesday’s issue, we looked at comments from 340B provider stakeholders, today we look more closely at the [...] …
New Hampshire Gov. Chris Sununu (R) yesterday signed a law prohibiting payers and pharmacy benefit managers (PBMs) from “discriminating against [...] …
A Canadian drug manufacturer recently announced that it will refund covered entities for hundreds of different products purchased between 2021 [...] …
Editor’s Note: In today’s issue, we look at the 340B provider community’s comments to CMS. In a future issue, we [...] …
A Japanese drug manufacturer has ended its 340B contract pharmacy restrictions in Maryland and Mississippi in conjunction with new contract [...] …
SPONSORED CONTENT
As the 340B program continues to grow in complexity, given the drug manufacturer restrictions, it is more important than ever for covered entities to have a firm grasp and understanding of the fees charged by their Third Party Adminisrators (TPAs) for their contract pharmacies. Whether it is
…
The West Virginia attorney general and multiple hospital groups recently urged a federal district judge to deny Novartis’ motion to [...] …
Two major drug manufacturers are suing Minnesota to block a new 340B contract pharmacy access law, which took effect this [...] …